The prevalence of hepatitis c virus antibody in HIV-Negative persons in Kenya, 2007

Abstract

The prevalence of hepatitis C virus (HCV) infection in the Kenyan population has not been previously determined. We estimated the Kenyan HCV prevalence in HIV-negative persons aged 15–64 years. This is a retrospective cross-sectional study using data from the 2007 Kenya AIDS Indicator Survey—a nationally representative sample of 15,853 persons aged 15–64 years who completed a health interview and provided a blood specimen. Of the 1,091 randomly selected participants, 50 tested positive for HCV antibody using the automated chemiluminescence immunoassay, corresponding to a weighted HCV antibody positivity rate of 4.4% (95% confidence interval: 3.3–5.9%) or 848,000 (range: 634,000–1,100,000) persons. Hepatitis C virus RNA, a marker for current infection, was not detected in any of the tested antibody-positive specimens. The high HCV antibody prevalence together with no current infection suggests that some HCV antibody serologic testing in Kenya may result in false positives whereas others may be because of spontaneous viral clearance.